AU2000255261A1 - Means for maintenance and/or correction of glucose concentration in blood - Google Patents

Means for maintenance and/or correction of glucose concentration in blood

Info

Publication number
AU2000255261A1
AU2000255261A1 AU2000255261A AU5526100A AU2000255261A1 AU 2000255261 A1 AU2000255261 A1 AU 2000255261A1 AU 2000255261 A AU2000255261 A AU 2000255261A AU 5526100 A AU5526100 A AU 5526100A AU 2000255261 A1 AU2000255261 A1 AU 2000255261A1
Authority
AU
Australia
Prior art keywords
blood
correction
maintenance
glucose concentration
polymeric matrix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2000255261A
Inventor
Iouri Gennadievich Bobkov
Anatoliy Borisovich Davydov
Iouri Tikhonovich Kalinin
Gennadiy Ljvovich Khromov
Boris Ivanovich Leonov
Tatjana Igorevna Solodkaya
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ctp Cable Technology Procurement AG
Original Assignee
C T P CABLE TECHNOLOGY PROCURE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by C T P CABLE TECHNOLOGY PROCURE filed Critical C T P CABLE TECHNOLOGY PROCURE
Publication of AU2000255261A1 publication Critical patent/AU2000255261A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Sampling And Sample Adjustment (AREA)

Abstract

The invention relates to preparations that are useful in maintaining mammalian blood glucose concentrations. These preparations contain insulin, and a polymeric matrix. The polymeric matrix has a core of biodegradable, hydrophobic polymer, and an outer shell of a biodegradable, hydrophobic polymer. Alternately, the formulations contain insulin, a polymeric matrix, and a histone.
AU2000255261A 2000-05-26 2000-05-26 Means for maintenance and/or correction of glucose concentration in blood Abandoned AU2000255261A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2000/004826 WO2001091784A1 (en) 2000-05-26 2000-05-26 Means for maintenance and/or correction of glucose concentration in blood

Publications (1)

Publication Number Publication Date
AU2000255261A1 true AU2000255261A1 (en) 2001-12-11

Family

ID=8163961

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2000255261A Abandoned AU2000255261A1 (en) 2000-05-26 2000-05-26 Means for maintenance and/or correction of glucose concentration in blood

Country Status (6)

Country Link
US (1) US7259139B1 (en)
EP (1) EP1289542B1 (en)
AT (1) ATE401095T1 (en)
AU (1) AU2000255261A1 (en)
DE (1) DE60039540D1 (en)
WO (1) WO2001091784A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007047997A2 (en) 2005-10-19 2007-04-26 Smartcells, Inc. Methods for reducing the mitogenicity of lectin compositions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2504408B1 (en) * 1981-04-24 1986-02-14 Couvreur Patrick PROCESS FOR THE PREPARATION OF SUBMICROSCOPIC PARTICLES, PARTICLES THUS OBTAINED AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
SU1011126A1 (en) * 1981-07-14 1983-04-15 Всесоюзный научно-исследовательский и испытательный институт медицинской техники Method of treating diabetes mellitus
US4666704A (en) * 1985-05-24 1987-05-19 International Minerals & Chemical Corp. Controlled release delivery system for macromolecules
IE61651B1 (en) * 1990-07-04 1994-11-16 Zambon Spa Programmed release oral solid pharmaceutical dosage form
US6277410B1 (en) * 1992-10-08 2001-08-21 Supratek Pharma Inc. Copolymer compositions for oral delivery
CA2228118A1 (en) * 1995-07-28 1997-02-13 Focal, Inc. Multiblock biodegradable hydrogels for use as controlled release agents for drugs delivery and tissue treatments agents
SE505146C2 (en) * 1995-10-19 1997-06-30 Biogram Ab Particles for delayed release

Also Published As

Publication number Publication date
ATE401095T1 (en) 2008-08-15
US7259139B1 (en) 2007-08-21
WO2001091784A1 (en) 2001-12-06
EP1289542B1 (en) 2008-07-16
DE60039540D1 (en) 2008-08-28
EP1289542A1 (en) 2003-03-12

Similar Documents

Publication Publication Date Title
AU2845599A (en) Pharmaceutical compositions and their use
WO2006052285A3 (en) Polymeric nanoparticles and nanogels for extraction and release of compounds
WO2005044224A3 (en) Drug delivery system based on polymer nanoshells
NO962088L (en) Preparation for in vivo production of therapeutic products
CA2411277A1 (en) Neurotoxin implant
AU3310595A (en) Compositions and methods for identifying biologically active molecules
NZ337845A (en) Non-antigenic branched polymer conjugates
WO1999036099A8 (en) Sustained release compositions, process for producing the same and utilization thereof
BR9910251A (en) Hematopoietic stimulation
AU6559800A (en) Use of hyaluronic acid derivatives in pharmaceutical preparations and biomaterials for the prevention and treatment of cutaneous scars
WO2002039948A3 (en) Cross-linked hyaluronic acid-laminin gels and use thereof in cell culture and medical implants
WO2000021572A3 (en) Hydrogels and water soluble polymeric carriers for drug delivery
AU2002350592A1 (en) Ph-sensitive polymer
WO2003068144A3 (en) Cytotoxic agents
AU6628496A (en) Polyether block copolymer micellar compositions for targeting biological agents
WO2002070030A8 (en) Grafts for the repair of osteochondral defects
WO2002064184A3 (en) Process for the preparation of a medical implant
WO1996003151A3 (en) Intracellular expression of carboxypeptidase g2 in enzyme prodrug therapy
WO2002060409A8 (en) Membrane for encapsulation chamber of cells producing at least a biologically active substance and bioartificial organ comprising same
ATE326264T1 (en) PHARMACEUTICAL FORMULATIONS WITH CONTROLLED RELEASE OF ACTIVE INGREDIENTS CONTAINING LACTIC ACID POLYMER AND THEIR PRODUCTION
AU1263400A (en) Stable aqueous insulin preparations without phenol and cresol
DE59407457D1 (en) BLOCKING THE ADMINISTRATION OF GermS IN HUMAN CELLS
PT983076E (en) Oxalate-degrading microorganisms or oxalate-degrading enzymes for preventing oxalate related disease
BRPI0414979A (en) solid preparation
AU4104397A (en) Implant consisting of a carrier material containing medical substances and method to produce such an implant